These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23863835)

  • 1. Differences in viral load testing methodology may play an important role in optimizing the initial management of HIV-infected pregnant women.
    Michalik DE; Batra JS
    J Int Assoc Provid AIDS Care; 2013; 12(4):225-6. PubMed ID: 23863835
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamics of HIV-1 viral load in pregnancy.
    Lillo FB; Bucceri AM; Bettini P; Farma E; Boeri E; Mastrorilli E; Rossi G; Vignali M; Varnier OE
    AIDS; 1997 Sep; 11(11):1397-8. PubMed ID: 9302452
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.
    Sitnitskaya Y; Rochford G; Rigaud M; Essajee S; Pollack H; Krasinski K; Borkowsky W
    Clin Infect Dis; 2001 Jul; 33(1):e3-7. PubMed ID: 11389511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.
    Shaheen F; Sison AV; McIntosh L; Mukhtar M; Pomerantz RJ
    J Hum Virol; 1999; 2(3):154-66. PubMed ID: 10413367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Generic HIV Viral Load assay with the Amplicor HIV-1 monitor v1.5 and Nuclisens HIV-1 EasyQ v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho Bora preparatory study.
    Rouet F; Foulongne V; Viljoen J; Steegen K; Becquart P; Valéa D; Danaviah S; Segondy M; Verhofstede C; Van de Perre P;
    J Virol Methods; 2010 Feb; 163(2):253-7. PubMed ID: 19837114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral treatment during pregnancy.
    Keiser O; Gayet-Ageron A; Rudin C; Brinkhof MW; Gremlich E; Wunder D; Drack G; Hirschel B; de Tejada BM; ;
    AIDS; 2008 Nov; 22(17):2323-30. PubMed ID: 18981771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV RNA viral load and CD4+ T-cell counts in HIV-infected pregnant women with and without treatment discontinuation in early pregnancy.
    Tamburrini E; Ravizza M; Floridia M; Tibaldi C; Alberico S; Anzidei G; Maccabruni A; Meloni A; Antoni AD; Mori F; Dalzero S; Conservan V; Pinnetti C; Ferrazzi E;
    Antivir Ther; 2008; 13(4):519-27. PubMed ID: 18672530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of HIV-1 drug resistance in antiretroviral-naive pregnant Thai women.
    Auswinporn S; Jenwitheesuk E; Panburana P; Sirinavin S; Vibhagool A; Chantratita W
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):818-21. PubMed ID: 12757232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
    Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of pregnancy in an HIV elite controller.
    Rutland E; Mani R
    Int J STD AIDS; 2010 Aug; 21(8):604-5. PubMed ID: 20975097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.
    Garcia PM; Kalish LA; Pitt J; Minkoff H; Quinn TC; Burchett SK; Kornegay J; Jackson B; Moye J; Hanson C; Zorrilla C; Lew JF
    N Engl J Med; 1999 Aug; 341(6):394-402. PubMed ID: 10432324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
    N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 viral load test approved by FDA.
    AIDS Patient Care STDS; 2007 Jun; 21(6):438-9. PubMed ID: 17594254
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance.
    Grant PM; Zolopa AR
    Curr Opin Investig Drugs; 2010 Aug; 11(8):901-10. PubMed ID: 20721832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course of children of human immunodeficiency virus-infected mothers in Taiwan.
    Yang SC; Lu CY; Lee CY; Hung CC; Chen MY; Chuang CY; Huang LM
    J Microbiol Immunol Infect; 2004 Aug; 37(4):225-30. PubMed ID: 15340650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Sperling RS; Shapiro DE; Coombs RW; Todd JA; Herman SA; McSherry GD; O'Sullivan MJ; Van Dyke RB; Jimenez E; Rouzioux C; Flynn PM; Sullivan JL
    N Engl J Med; 1996 Nov; 335(22):1621-9. PubMed ID: 8965861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.
    Ioannidis JP; Abrams EJ; Ammann A; Bulterys M; Goedert JJ; Gray L; Korber BT; Mayaux MJ; Mofenson LM; Newell ML; Shapiro DE; Teglas JP; Wilfert CM
    J Infect Dis; 2001 Feb; 183(4):539-45. PubMed ID: 11170978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk.
    Shapiro RL; Ndung'u T; Lockman S; Smeaton LM; Thior I; Wester C; Stevens L; Sebetso G; Gaseitsiwe S; Peter T; Essex M
    J Infect Dis; 2005 Sep; 192(5):713-9. PubMed ID: 16088820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misdiagnosed HIV infection in pregnant women initiating universal ART in South Africa.
    Hsiao NY; Zerbe A; Phillips TK; Myer L; Abrams EJ
    J Int AIDS Soc; 2017 Aug; 20(Suppl 6):21758. PubMed ID: 28872277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.